Press release
Pharmacogenomics Market to Witness Remarkable Growth with Pharmigene, Abbott, Agilent Technologies
The Global Pharmacogenomics Market is expected to grow at 11.7% CAGR from 2025 to 2032.The Latest detailed study on the global Pharmacogenomics Market 2025-2032, Outlook is performed by determining industry drivers, dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. The Pharmacogenomics Market report has been designed after a Research Scope and Methodologies of various segments such as share, demand analysis, growth figure, SWOT Analysis and recent trends and so on. Furthermore, this report comprises important statistics, opportunities current industry trends, new innovations, forthcoming updates, and the market environment.
The market report study added detailed analysis of the competitive landscape of the industry and deep information on the top vendors and other key factors that will threaten the growth of the global industry. This research study delivers an immensely effective business strategy through which topmost industry players can attain massive profits by policymakers, stakeholders, investors, making necessary business-oriented decisions.
Request Sample Copy of Report @ https://www.coherentmarketinsights.com/insight/request-sample/1053
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis:
Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pharmigene, Abbott, Agilent Technologies, Inc., QIAGEN, GE HealthCare, Empire Genomics, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies plc., PerkinElmer Inc., Myriad Genetics, Inc., Illumina, Inc., Macrogen, Inc., BGI Genomics, Eurofins Scientific, MapMyGenome, and Invitae Corporation
Pharmacogenomics Market Segmentation and Classification:
◉ By Technology: DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, and Others
◉ By Application: Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Pain Management, and Others
◉ By End User: Hospitals & Clinics, Research Institutions and Academic Institutes, Diagnostic Laboratories, and Others
Geographical Landscape of the Pharmacogenomics Market:
The Pharmacogenomics Market report provides in-depth insights into the market landscape, breaking it down into sub-regions and individual countries. This section of the report not only showcases the market share of each country and sub-region but also uncovers potential profit opportunities within these areas.
» North America (United States, Canada, and Mexico)
» Europe (Germany, France, UK, Russia, Italy)
» Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
» Latin America (Brazil, Argentina, Colombia)
» Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
Purchase This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1053
Highlights of Our Report:
⏩ An exhaustive breakdown of end-user segments, depicting the market's spread across various applications and industries.
⏩ A deep dive into the manufacturing capabilities, production volumes, and technological innovations within the Pharmacogenomics Market.
⏩ Strategic analysis of Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis etc.
⏩ An in-depth review of company profiles, spotlighting major players and their strategic manoeuvres in the market's competitive arena.
⏩ Conclusive study concerning the expansion plot of Pharmacogenomics Marketplace for upcoming years.
⏩ In-depth understanding of Pharmacogenomics Market market-particular drivers, constraints and major small markets.
⏩ Advantageous impact within important technological and market latest trends placing the Pharmacogenomics Market.
Strategic Points lined in Table of Content of Pharmacogenomics Market:
- Chapter 1: Introduction, market actuation product Objective of Study and analysis Scope the world Pharmacogenomics Market (2025-2032).
- Chapter 2: Exclusive outline - the fundamental info of the world Pharmacogenomics Market.
- Chapter 3: Ever-changing Impact on Market Dynamics- Drivers, Trends and Challenges & Opportunities of the world Pharmacogenomics Market Analysis.
- Chapter 4: Presenting the world Pharmacogenomics Market correlational analysis, Porters 5 Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
- Chapter 5: Displaying the by kind, user and Region/Country 2025-2032.
- Chapter 6: Evaluating the leading makers of the world Pharmacogenomics Market that consists of its Competitive Landscape, generation Analysis, BCG Matrix & Company Profile.
- Chapter: To estimate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these numerous regions (2025-2032).
... To be continued
Direct Purchase of Pharmacogenomics Market Report, Click Here: https://www.coherentmarketinsights.com/insight/buy-now/1053
Reasons to buy Pharmacogenomics Market research report:
■ Access to valuable information: Pharmacogenomics Market research report provides access to valuable information and data that can help to make informed decisions.
■ Gain competitive intelligence: Pharmacogenomics Market research report provides insights into the competitive landscape, including information on the leading players, their market share, and their strategies. This can help businesses develop effective strategies for competing in the market.
■ Make informed investment decisions: Pharmacogenomics Market research report provides valuable insights for users, including analysis of market trends, growth potential, and risks. This can help to make investment decisions and minimize their risk.
■ Stay up-to-date on industry developments: Pharmacogenomics Market research report also provides regular updates on industry developments, including new product launches, mergers and acquisitions, and regulatory changes. This can help users to stay ahead of the curve and adapt to changing market conditions.
Report Includes Following Questions:
What will be the size of the Pharmacogenomics Market in the coming years?
2. Which segment will top the Pharmacogenomics Market?
3. What are the primary driving factors of the global Market?
4. What is the nature of the competitive landscape of the Pharmacogenomics Market?
5. What are the go-to strategies accepted in the Pharmacogenomics Market?
6. What are the key driving factors of the global Pharmacogenomics Market?
7. Which are the dominant players of the Pharmacogenomics Market?
8. How will the market development trends change in the next five years?
Author of this marketing PR:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, have a sales office at global financial capital in the U.S., and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed to playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market to Witness Remarkable Growth with Pharmigene, Abbott, Agilent Technologies here
News-ID: 3894031 • Views: …
More Releases from Coherent Market Insights

Space Ground Station Equipment Market: An Analysis of Size, Shares, Business Gro …
Space Ground Station Equipment Market is estimated to be valued at USD 10,826.8 Mn in 2025 and is expected to reach USD 18,833.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.23% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Space Ground Station Equipment Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a…

Crude Transportation Market 2025 Size, Industry Revenue, Growth Insights, Top Pl …
The Crude Transportation Market size is estimated to be valued at USD 25.65 Bn in 2025 and is expected to reach USD 39.09 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Crude Transportation Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective…

Computer Software Assurance (CSA) Market Revenue Growth 2025, Emerging Technolog …
Computer Software Assurance (CSA) Market is estimated to be valued at USD 10.83 Bn in 2025 and is expected to reach USD 25.48 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 13% from 2025 to 2032
The latest research study released by Coherent Market Insights on "Computer Software Assurance (CSA) Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a…

Electric Lunch Box Market Outlook, Trend Analysis, Current Growth, Future Scope …
The Electric Lunch Box Market size is estimated to be valued at US$ 775.4 Mn in 2025 and is expected to reach US$ 1,212.9 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Electric Lunch Box Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…